Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Andrew Combs

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
American Journal of Obstetrics and Gynecology|March 26, 2022
Society for Maternal-Fetal Medicine Special Statement: Checklist for pregnancies resulting from in vitro fertilization, Reem S Abu-Rustum, C Andrew Combs, et al.
American Journal of Obstetrics and Gynecology|March 8, 2017
A multicenter prospective study of neonatal outcomes at less than 32 weeks associated with indications for maternal admission and deliveryThomas J Garite, C Andrew Combs, Kimberly Maurel, et al.
American Journal of Obstetrics and Gynecology|March 6, 2016
Vasa previa: diagnosis and managementMorgan L Swank, Thomas J Garite, Kimberly Maurel, et al.
American Journal of Obstetrics and Gynecology|September 14, 2019
Placental growth factor predicts time to delivery in women with signs or symptoms of early preterm preeclampsia: a prospective multicenter studyJohn R Barton, Doug A Woelkers, Roger B Newman, et al.
AJP Reports|March 29, 2017
Massive Urinary Protein Excretion Associated with Greater Neonatal Risk in PreeclampsiaJulio Mateus, Roger Newman, Baha M Sibai, et al.
American Journal of Obstetrics & Gynecology MFM|February 16, 2023
Booster course of antenatal corticosteroids after preterm prelabor rupture of membranes: a double-blind randomized trialRichard Porreco, Thomas J Garite, C Andrew Combs, et al.
AJP Reports|May 3, 2019
Cervical Pessary versus Expectant Management for the Prevention of Delivery Prior to 36 Weeks in Women with Placenta Previa: A Randomized Controlled TrialIrene A Stafford, Thomas J Garite, Kimberly Maurel, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|April 20, 2023
Progestogen maintenance therapy for prolongation of pregnancy after an episode of preterm labour: A systematic review and meta-analysisSofie H Breuking, Annemijn A De Ruigh, Frederik J R Hermans, et al.
American Journal of Obstetrics and Gynecology|May 17, 2015
17-hydroxyprogesterone caproate for preterm rupture of the membranes: a multicenter, randomized, double-blind, placebo-controlled trialC Andrew Combs, Thomas J Garite, Kimberly Maurel, et al.
Journal of Medical Screening|September 13, 2019
Evaluation of a novel screening method for fetal aneuploidy using cell-free DNA in maternal plasmaRichard P Porreco, Matthew Sekedat, Allan Bombard, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
American Journal of Obstetrics and Gynecology|March 26, 2022
Society for Maternal-Fetal Medicine Special Statement: Checklist for pregnancies resulting from in vitro fertilization, Reem S Abu-Rustum, C Andrew Combs, et al.
American Journal of Obstetrics and Gynecology|March 8, 2017
A multicenter prospective study of neonatal outcomes at less than 32 weeks associated with indications for maternal admission and deliveryThomas J Garite, C Andrew Combs, Kimberly Maurel, et al.
American Journal of Obstetrics and Gynecology|March 6, 2016
Vasa previa: diagnosis and managementMorgan L Swank, Thomas J Garite, Kimberly Maurel, et al.
American Journal of Obstetrics and Gynecology|September 14, 2019
Placental growth factor predicts time to delivery in women with signs or symptoms of early preterm preeclampsia: a prospective multicenter studyJohn R Barton, Doug A Woelkers, Roger B Newman, et al.
AJP Reports|March 29, 2017
Massive Urinary Protein Excretion Associated with Greater Neonatal Risk in PreeclampsiaJulio Mateus, Roger Newman, Baha M Sibai, et al.
American Journal of Obstetrics & Gynecology MFM|February 16, 2023
Booster course of antenatal corticosteroids after preterm prelabor rupture of membranes: a double-blind randomized trialRichard Porreco, Thomas J Garite, C Andrew Combs, et al.
AJP Reports|May 3, 2019
Cervical Pessary versus Expectant Management for the Prevention of Delivery Prior to 36 Weeks in Women with Placenta Previa: A Randomized Controlled TrialIrene A Stafford, Thomas J Garite, Kimberly Maurel, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|April 20, 2023
Progestogen maintenance therapy for prolongation of pregnancy after an episode of preterm labour: A systematic review and meta-analysisSofie H Breuking, Annemijn A De Ruigh, Frederik J R Hermans, et al.
American Journal of Obstetrics and Gynecology|May 17, 2015
17-hydroxyprogesterone caproate for preterm rupture of the membranes: a multicenter, randomized, double-blind, placebo-controlled trialC Andrew Combs, Thomas J Garite, Kimberly Maurel, et al.
Journal of Medical Screening|September 13, 2019
Evaluation of a novel screening method for fetal aneuploidy using cell-free DNA in maternal plasmaRichard P Porreco, Matthew Sekedat, Allan Bombard, et al.
Pageof 8